On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
We are very excited to launch our new website! Please take a few moments to click around and explore...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...